The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
Clinical trial NCT03201848 · UNKNOWN
Trial details
- NCT number
- NCT03201848
- Sponsor
- Qidong Gaitianli Medicines Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2023-10-14
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.